180
Participants
Start Date
December 13, 2022
Primary Completion Date
October 31, 2027
Study Completion Date
November 30, 2027
KL1333
Twice daily
Placebo
Twice daily
NOT_YET_RECRUITING
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan
NOT_YET_RECRUITING
IRCCS Institute of Neurological Sciences of Bologna- Universita di Bologna, Bologna
RECRUITING
Akron Children's Hospital, Akron
NOT_YET_RECRUITING
Azienda Ospedaliero Universitaria Pisana, Pisa
RECRUITING
The University of Texas Health Science Center at Houston, Houston
NOT_YET_RECRUITING
Azienda Ospedaliera Universitaria Gaetano Martino Messina, Messina
RECRUITING
Hopital Universitaire de Bruxelles (H.U.B)/ Academisch Ziekenhuis Brussel, Brussels
RECRUITING
Universitair Ziekenhuis Gent, Ghent
RECRUITING
Universitair Ziekenhuis Leuven Gasthuisberg Campus, Leuven
RECRUITING
Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen
RECRUITING
Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux
RECRUITING
Hopital Roger Salengro, CHRU de Lille, Lille
RECRUITING
Centre Hospitalier Universitaire de Nice, Hopital Pasteur 2, Nice
RECRUITING
CHU de NICE - Hôpital Archet 2, Nice
RECRUITING
Groupe Hospitalier Pitie-Salpetriere, Paris
RECRUITING
CIBERER- IDIBAPS, Faculty of Medicine, University of Barcelona, Barcelona
COMPLETED
Hospital de la Santa Creu i Sant Pau, Barcelona
RECRUITING
Hospital General Universitario de Catalunya, Barcelona
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Department of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge
RECRUITING
University College London Hospitals Nhs Foundation Trust, London
RECRUITING
Royal Victoria Infirmary - The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle
NOT_YET_RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma
Lead Sponsor
Abliva AB
INDUSTRY